Download PDF
Semin Thromb Hemost 2016; 42(05): 463-470
DOI: 10.1055/s-0036-1571313
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Bleeding Assessment Tools: Limits and Advantages for the Diagnosis and Prognosis of Inherited Bleeding Disorders

Alberto Tosetto
1   Hematology Department, S. Bortolo Hospital, Vicenza, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
20 April 2016 (online)

    Permissions and Reprints

Abstract

Bleeding assessment tools were first developed essentially as research tools, for the quantification of bleeding symptoms and the study of phenotype/genotype correlations. Interestingly, these tools have been proven useful also for clinicians diagnosing and treating bleeding disorders. The main advantage of these tools is the standardization of the diagnostic process, allowing the introduction of criteria with known specificity and sensitivity for the diagnosis of the most common mild bleeding disorders, particularly von Willebrand disease. This is important also for a rational approach to the laboratory diagnosis because for many mild bleeding disorders, a complex laboratory workup is required. Bleeding assessment tools should always be complemented by ancillary coagulation screening tests to exclude the presence of a bleeding disorder, however. Finally, bleeding severity assessed by such tools has been shown to correlate with the long-term probability of bleeding. Therefore, the bleeding assessment could become an important marker of disease severity.

Keywords

bleeding disorders - von Willebrand disease - diagnosis - prognosis - questionnaires
 

  • References

  • 1 Coller BS, Schneiderman PI. Clinical evaluation of hemorrhagic disorders: the bleeding history and differential diagnosis of purpura. In: Hoffman R, Benz EJ, Shattil JS, et al., eds. Hematology: Basic Principles and Practice. Philadelphia, PA: Elsevier Churchill Livingstone; 2007
    Google Scholar
  • 2 Greaves M, Watson HG. Approach to the diagnosis and management of mild bleeding disorders. J Thromb Haemost 2007; 5 (Suppl. 01) 167-174
    CrossrefPubMedGoogle Scholar
  • 3 Rodeghiero F, Tosetto A, Castaman G. How to estimate bleeding risk in mild bleeding disorders. J Thromb Haemost 2007; 5 (Suppl. 01) 157-166
    CrossrefPubMedGoogle Scholar
  • 4 Hayward CP. Diagnosis and management of mild bleeding disorders. Hematology (Am Soc Hematol Educ Program) 2005; 1: 423-428
    PubMedGoogle Scholar
  • 5 Narr BJ, Hansen TR, Warner MA. Preoperative laboratory screening in healthy Mayo patients: cost-effective elimination of tests and unchanged outcomes. Mayo Clin Proc 1991; 66 (2) 155-159
    CrossrefPubMedGoogle Scholar
  • 6 Leung LLK. Perioperative evaluation of bleeding diathesis. Hematology (Am Soc Hematol Educ Program) 2006; 2006 (1) 457-461
    CrossrefPubMedGoogle Scholar
  • 7 Friberg B, Ornö AK, Lindgren A, Lethagen S. Bleeding disorders among young women: a population-based prevalence study. Acta Obstet Gynecol Scand 2006; 85 (2) 200-206
    CrossrefPubMedGoogle Scholar
  • 8 Rodeghiero F, Castaman G, Tosetto A , et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2005; 3 (12) 2619-2626
    CrossrefPubMedGoogle Scholar
  • 9 McKay H, Derome F, Haq MA , et al. Bleeding risks associated with inheritance of the Quebec platelet disorder. Blood 2004; 104 (1) 159-165
    CrossrefPubMedGoogle Scholar
  • 10 Silwer J. von Willebrand's disease in Sweden. Acta Paediatr Scand Suppl 1973; 238: 1-159
    PubMedGoogle Scholar
  • 11 Miller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand's disease. I. Phenotypic variation within families. Blood 1979; 54 (1) 117-136
    PubMedGoogle Scholar
  • 12 Srámek A, Eikenboom JC, Briët E, Vandenbroucke JP, Rosendaal FR. Usefulness of patient interview in bleeding disorders. Arch Intern Med 1995; 155 (13) 1409-1415
    CrossrefPubMedGoogle Scholar
  • 13 Mauser Bunschoten EP, van Houwelingen JC, Sjamsoedin Visser EJ, van Dijken PJ, Kok AJ, Sixma JJ. Bleeding symptoms in carriers of hemophilia A and B. Thromb Haemost 1988; 59 (3) 349-352
    PubMedGoogle Scholar
  • 14 Quiroga T, Goycoolea M, Panes O , et al. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica 2007; 92 (3) 357-365
    CrossrefPubMedGoogle Scholar
  • 15 Mauer AC, Khazanov NA, Levenkova N , et al. Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults. J Thromb Haemost 2011; 9 (1) 100-108
    CrossrefPubMedGoogle Scholar
  • 16 The Medical Research Council's General Practice Research Framework. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet 1998; 351 (9098) 233-241
    CrossrefPubMedGoogle Scholar
  • 17 Tosetto A, Castaman G, Rodeghiero F. Bleeders, bleeding rates, and bleeding score. J Thromb Haemost 2013; 11 (Suppl. 01) 142-150
    CrossrefPubMedGoogle Scholar
  • 18 Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999; 5 (1) 40-48
    CrossrefPubMedGoogle Scholar
  • 19 Rodeghiero F, Tosetto A, Abshire T , et al; ISTH/SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 8 (9) 2063-2065
    CrossrefPubMedGoogle Scholar
  • 20 Deforest M, Grabell J, Albert S , et al. Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease. Haemophilia 2015; 21 (5) e384-e388
    CrossrefPubMedGoogle Scholar
  • 21 Castaman G, Tosetto A, Federici AB, Rodeghiero F. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance. Thromb Haemost 2011; 105 (4) 647-654
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Sadler JE, Rodeghiero F ; ISTH SSC Subcommittee on von Willebrand Factor. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005; 3 (4) 775-777
    CrossrefPubMedGoogle Scholar
  • 23 Tosetto A, Rodeghiero F, Castaman G , et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006; 4 (4) 766-773
    CrossrefPubMedGoogle Scholar
  • 24 Goodeve A, Eikenboom J, Castaman G , et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007; 109 (1) 112-121
    CrossrefPubMedGoogle Scholar
  • 25 Biss TT, Blanchette VS, Clark DS , et al. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost 2010; 8 (5) 950-956
    PubMedGoogle Scholar
  • 26 Biss TT, Blanchette VS, Clark DS, Wakefield CD, James PD, Rand ML. Use of a quantitative pediatric bleeding questionnaire to assess mucocutaneous bleeding symptoms in children with a platelet function disorder. J Thromb Haemost 2010; 8 (6) 1416-1419
    CrossrefPubMedGoogle Scholar
  • 27 Tosetto A, Castaman G, Plug I, Rodeghiero F, Eikenboom J. Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation. J Thromb Haemost 2011; 9 (6) 1143-1148
    CrossrefPubMedGoogle Scholar
  • 28 Tosetto A, Rodeghiero F, Castaman G , et al. A comparison between two semi-quantitative bleeding scales for the diagnosis and assessment of bleeding severity in type 1 von Willebrand disease. Haemophilia 2011; 17 (1) 165-166
    CrossrefPubMedGoogle Scholar
  • 29 Rydz N, James PD. The evolution and value of bleeding assessment tools. J Thromb Haemost 2012; 10 (11) 2223-2229
    CrossrefPubMedGoogle Scholar
  • 30 Bowman M, Riddel J, Rand ML, Tosetto A, Silva M, James PD. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost 2009; 7 (8) 1418-1421
    CrossrefPubMedGoogle Scholar
  • 31 Bidlingmaier C, Grote V, Budde U, Olivieri M, Kurnik K. Prospective evaluation of a pediatric bleeding questionnaire and the ISTH bleeding assessment tool in children and parents in routine clinical practice. J Thromb Haemost 2012; 10 (7) 1335-1341
    CrossrefPubMedGoogle Scholar
  • 32 Lowe GC, Lordkipanidzé M, Watson SP ; UK GAPP study group. Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders. J Thromb Haemost 2013; 11 (9) 1663-1668
    CrossrefPubMedGoogle Scholar
  • 33 Elbatarny M, Mollah S, Grabell J , et al; Zimmerman Program Investigators. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia 2014; 20 (6) 831-835
    CrossrefPubMedGoogle Scholar
  • 34 Tosetto A, Castaman G. How I treat type 2 variant forms of von Willebrand disease. Blood 2015; 125 (6) 907-914
    CrossrefPubMedGoogle Scholar
  • 35 Bowman M, Mundell G, Grabell J , et al. Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease. J Thromb Haemost 2008; 6 (12) 2062-2066
    CrossrefPubMedGoogle Scholar
  • 36 Castaman G, Federici AB, Tosetto A , et al. Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients. J Thromb Haemost 2012; 10 (4) 632-638
    CrossrefPubMedGoogle Scholar
  • 37 Federici AB, Bucciarelli P, Castaman G , et al. Incidence and determinants of bleeding in different types of von Willebrand disease: results of the first prospective multicenter study on 814 Italian patients. ASH Annual Meeting Abstracts 2007; 110 (11) 713
    PubMedGoogle Scholar
  • 38 Rodeghiero F, Castaman G, Tosetto A. How I treat von Willebrand disease. Blood 2009; 114 (6) 1158-1165
    CrossrefPubMedGoogle Scholar
  • 39 Tosetto A, Castaman G, Rodeghiero F. Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach. Blood 2008; 111 (8) 3998-4003
    CrossrefPubMedGoogle Scholar
  • 40 Penaloza A, Verschuren F, Meyer G , et al. Comparison of the unstructured clinician gestalt, the wells score, and the revised Geneva score to estimate pretest probability for suspected pulmonary embolism. Ann Emerg Med 2013; 62 (2) 117-124.e2
    CrossrefPubMedGoogle Scholar
  • 41 Kabrhel C, Camargo Jr CA, Goldhaber SZ. Clinical gestalt and the diagnosis of pulmonary embolism: does experience matter?. Chest 2005; 127 (5) 1627-1630
    CrossrefPubMedGoogle Scholar
  • 42 Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med 2015; 372 (9) 793-795
    CrossrefPubMedGoogle Scholar